Brown Brothers Harriman & Co. Increases Position in Relx Plc (NYSE:RELX)

Brown Brothers Harriman & Co. grew its holdings in Relx Plc (NYSE:RELX) by 218.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 965 shares of the technology company’s stock after purchasing an additional 662 shares during the quarter. Brown Brothers Harriman & Co.’s holdings in Relx were worth $44,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. Thrivent Financial for Lutherans lifted its holdings in shares of Relx by 83.0% in the 3rd quarter. Thrivent Financial for Lutherans now owns 10,665 shares of the technology company’s stock worth $506,000 after acquiring an additional 4,836 shares during the last quarter. Charles Schwab Investment Management Inc. grew its holdings in shares of Relx by 13.3% in the third quarter. Charles Schwab Investment Management Inc. now owns 120,300 shares of the technology company’s stock valued at $5,709,000 after purchasing an additional 14,088 shares in the last quarter. BNP Paribas Financial Markets increased its stake in Relx by 20.7% during the 3rd quarter. BNP Paribas Financial Markets now owns 42,281 shares of the technology company’s stock worth $2,007,000 after buying an additional 7,239 shares during the period. Glenmede Trust Co. NA boosted its position in Relx by 2.9% in the 3rd quarter. Glenmede Trust Co. NA now owns 14,196 shares of the technology company’s stock valued at $674,000 after buying an additional 405 shares during the period. Finally, Verition Fund Management LLC acquired a new position in shares of Relx in the third quarter worth $255,000. 15.02% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities research analysts have issued reports on RELX shares. The Goldman Sachs Group initiated coverage on Relx in a research report on Wednesday, March 26th. They issued a “buy” rating on the stock. StockNews.com cut shares of Relx from a “buy” rating to a “hold” rating in a research report on Tuesday, March 4th. Barclays upgraded shares of Relx from an “equal weight” rating to an “overweight” rating in a research note on Friday, March 14th. Finally, Redburn Atlantic assumed coverage on Relx in a report on Wednesday, January 8th. They set a “buy” rating for the company. One investment analyst has rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Buy”.

Relx Trading Up 0.5 %

NYSE RELX opened at $50.93 on Thursday. The firm’s fifty day moving average is $49.59 and its two-hundred day moving average is $47.89. Relx Plc has a one year low of $40.25 and a one year high of $51.99. The company has a debt-to-equity ratio of 1.46, a quick ratio of 0.47 and a current ratio of 0.52. The firm has a market cap of $94.53 billion, a PE ratio of 27.38, a P/E/G ratio of 2.73 and a beta of 0.84.

Relx Increases Dividend

The company also recently disclosed a semi-annual dividend, which will be paid on Wednesday, June 25th. Investors of record on Friday, May 9th will be given a $0.5586 dividend. This represents a yield of 1.6%. This is a positive change from Relx’s previous semi-annual dividend of $0.23. The ex-dividend date of this dividend is Friday, May 9th. Relx’s dividend payout ratio (DPR) is 59.68%.

Relx Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.